Vaishali Pharma

{
  "main_header": {
    "sid": 1002804,
    "name": "Vaishali Pharma",
    "stock_name": "Vaishali Pharma",
    "full_name": "Vaishali Pharma Ltd",
    "name_url": "stocks-analysis/vaishali-pharma",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "7.29",
    "chg": -0.07,
    "chgp": "-0.95%",
    "dir": -1,
    "prev_price": "7.36",
    "mcapval": "95.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "VAISHALI",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE972X01022",
    "curr_date": "Jun 25, 03:30 PM",
    "curr_time": "15:32 PM",
    "last_traded_at": "Jun 25, 03:30 PM IST",
    "bse_nse_vol": 28568,
    "exc_status": "Active",
    "traded_date": "Jun 25, 2026",
    "traded_date_str": "2026 06 25",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/vaishali-pharma-1002804-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Vaishali Pharma Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vaishali-pharma-ltd-is-rated-sell-4075949",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/VaishaliPharmaL_mojoScore_4075949.png",
        "date": "2026-06-28 10:10:06",
        "description": "Vaishali Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 June 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Vaishali Pharma Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vaishali-pharma-ltd-is-rated-sell-4055965",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/VaishaliPharmaL_mojoScore_4055965.png",
        "date": "2026-06-16 10:10:04",
        "description": "Vaishali Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 16 June 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Vaishali Pharma Gains 3.26%: Key Financial and Valuation Shifts Drive Weekly Move",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vaishali-pharma-gains-326-key-financial-and-valuation-shifts-drive-weekly-move-4051985",
        "imagepath": "",
        "date": "2026-06-13 16:13:20",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>1 June:</strong> Q4 FY26 results reveal profitability collapse amid margin pressures</p>\n                    <p><strong>2 June:</strong> Positive financial trend reported despite sales decline</p>\n                    <p><strong>2 June:</strong> Valuation parameters shift, signalling renewed price attractiveness</p>\n                    <p><strong>5 June:</strong> Week closes at Rs.7.28, up 3.26% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.7.05</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><..."
      },
      {
        "title": "Vaishali Pharma Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vaishali-pharma-ltd-is-rated-sell-by-marketsmojo-4036023",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/VaishaliPharmaL_mojoScore_4036023.png",
        "date": "2026-06-04 10:10:04",
        "description": "Vaishali Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 04 June 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Are Vaishali Pharma Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-vaishali-pharma-ltd-latest-results-good-or-bad-4032481",
        "imagepath": "",
        "date": "2026-06-02 19:37:54",
        "description": "Vaishali Pharma Ltd's latest financial results for Q4 FY26 indicate significant operational challenges despite a modest recovery in net sales. The company reported consolidated net sales of ₹26.93 crores, reflecting a quarter-on-quarter increase of 9.25% from ₹24.65 crores in Q3 FY26. However, this recovery follows a notable decline of 26.31% in the previous quarter, highlighting volatility in revenue generation.\n\nIn terms of profitability, the consolidated net profit was ₹0.41 crores, which represents a substantial decline of 68.94% from the prior quarter. This sharp drop in profit occurred alongside a negative operating margin of -0.74%, a stark contrast to the positive margins reported in earlier quarters. The operating profit before depreciation, interest, tax, and other income (PBDIT excluding OI) turned negative at -₹0.20 crores, indicating that the core pharmaceutical operations are currently loss-ma..."
      },
      {
        "title": "Vaishali Pharma Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vaishali-pharma-ltd-valuation-shifts-signal-renewed-price-attractiveness-4029497",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/VaishaliPharmaL_valuationdot_4029497.png",
        "date": "2026-06-02 08:05:08",
        "description": "Vaishali Pharma Ltd has witnessed a notable shift in its valuation parameters, moving from a risky to an attractive investment grade despite ongoing sector headwinds. The company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present a more compelling case relative to its historical averages and peer group, signalling a potential inflection point for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Vaishali Pharma Ltd Reports Positive Financial Trend Amidst Sales Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vaishali-pharma-ltd-reports-positive-financial-trend-amidst-sales-decline-4028985",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/VaishaliPharmaL_fintrenddot_4028985.png",
        "date": "2026-06-02 08:00:23",
        "description": "Vaishali Pharma Ltd has demonstrated a notable shift in its financial trajectory during the quarter ended March 2026, with an improved financial trend score signalling positive momentum despite a decline in net sales. The company’s latest quarterly performance reveals a complex picture of margin pressures and operational challenges, set against a backdrop of a recovering profit after tax and a micro-cap valuation."
      },
      {
        "title": "Vaishali Pharma Q4 FY26: Profitability Collapse Amid Margin Pressures and Operational Setbacks",
        "link": "https://www.marketsmojo.com/news/result-analysis/vaishali-pharma-q4-fy26-profitability-collapse-amid-margin-pressures-and-operational-setbacks-4028881",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/VaishaliPharma_quaterlyResult_4028881.png",
        "date": "2026-06-01 18:51:33",
        "description": "Vaishali Pharma Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹92.00 crores, posted a consolidated net profit of ₹0.41 crores in Q4 FY26 (January-March 2026), representing a sharp decline of 68.94% quarter-on-quarter from ₹1.32 crores in Q3 FY26 (October-December 2025). The dramatic profit contraction came despite a modest 9.25% sequential revenue increase to ₹26.93 crores, as the company grappled with negative operating margins and heightened dependence on non-operating income. The stock has been under severe pressure, declining 44.60% over the past year and currently trading at ₹7.03, down 48.27% from its 52-week high of ₹13.59."
      },
      {
        "title": "Vaishali Pharma Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vaishali-pharma-ltd-is-rated-strong-sell-4009272",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/VaishaliPharmaL_mojoScore_4009272.png",
        "date": "2026-05-24 10:10:15",
        "description": "Vaishali Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 Feb 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 24 May 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      }
    ],
    "total": 90,
    "sid": "1002804",
    "stock_news_url": "https://www.marketsmojo.com/news/vaishali-pharma-1002804"
  },
  "announcements": [
    {
      "details": "Vaishali Pharma Limited has informed the Exchange regarding Resignation of Ms Khushboo M Panchal as Company Secretary & Compliance Officer of the company w.e.f. October 31, 2019.",
      "source": "NSE",
      "caption": "Vaishali Pharma Limited - Resignation",
      "datetime": "01-Nov-2019"
    },
    {
      "details": "Vaishali Pharma Limited has informed the Exchange regarding allotment of 3954828 securities pursuant to Bonus at its meeting held on October 19, 2019",
      "source": "NSE",
      "caption": "Vaishali Pharma Limited - Allotment of Securities",
      "datetime": "22-Oct-2019"
    },
    {
      "details": "Vaishali Pharma Limited has informed the Exchange that the Company has fixed Record Date as October 18, 2019 for the purpose of Allotment of Bonus Shares .(Revised)",
      "source": "NSE",
      "caption": "Vaishali Pharma Limited - Record Date",
      "datetime": "16-Oct-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Vaishali Pharma Ltd has announced <strong>2:10</strong> stock split, ex-date: 15 Oct 24",
          "dt": "2024-10-15",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Vaishali Pharma Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 15 Oct 24",
          "dt": "2024-10-15",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Vaishali Pharma Ltd is Rated Sell

2026-06-28 10:10:06

Vaishali Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 June 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Vaishali Pharma Ltd is Rated Sell

2026-06-16 10:10:04

Vaishali Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 16 June 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Vaishali Pharma Gains 3.26%: Key Financial and Valuation Shifts Drive Weekly Move

2026-06-13 16:13:20

Key Events This Week

1 June: Q4 FY26 results reveal profitability collapse amid margin pressures

2 June: Positive financial trend reported despite sales decline

2 June: Valuation parameters shift, signalling renewed price attractiveness

5 June: Week closes at Rs.7.28, up 3.26% for the week

Week Open

Rs.7.05

Week Close

<...

Read full news article

Vaishali Pharma Ltd is Rated Sell by MarketsMOJO

2026-06-04 10:10:04

Vaishali Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 04 June 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Are Vaishali Pharma Ltd latest results good or bad?

2026-06-02 19:37:54

Vaishali Pharma Ltd's latest financial results for Q4 FY26 indicate significant operational challenges despite a modest recovery in net sales. The company reported consolidated net sales of ₹26.93 crores, reflecting a quarter-on-quarter increase of 9.25% from ₹24.65 crores in Q3 FY26. However, this recovery follows a notable decline of 26.31% in the previous quarter, highlighting volatility in revenue generation. In terms of profitability, the consolidated net profit was ₹0.41 crores, which represents a substantial decline of 68.94% from the prior quarter. This sharp drop in profit occurred alongside a negative operating margin of -0.74%, a stark contrast to the positive margins reported in earlier quarters. The operating profit before depreciation, interest, tax, and other income (PBDIT excluding OI) turned negative at -₹0.20 crores, indicating that the core pharmaceutical operations are currently loss-ma...

Read full news article

Vaishali Pharma Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-06-02 08:05:08

Vaishali Pharma Ltd has witnessed a notable shift in its valuation parameters, moving from a risky to an attractive investment grade despite ongoing sector headwinds. The company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present a more compelling case relative to its historical averages and peer group, signalling a potential inflection point for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Vaishali Pharma Ltd Reports Positive Financial Trend Amidst Sales Decline

2026-06-02 08:00:23

Vaishali Pharma Ltd has demonstrated a notable shift in its financial trajectory during the quarter ended March 2026, with an improved financial trend score signalling positive momentum despite a decline in net sales. The company’s latest quarterly performance reveals a complex picture of margin pressures and operational challenges, set against a backdrop of a recovering profit after tax and a micro-cap valuation.

Read full news article

Vaishali Pharma Q4 FY26: Profitability Collapse Amid Margin Pressures and Operational Setbacks

2026-06-01 18:51:33

Vaishali Pharma Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹92.00 crores, posted a consolidated net profit of ₹0.41 crores in Q4 FY26 (January-March 2026), representing a sharp decline of 68.94% quarter-on-quarter from ₹1.32 crores in Q3 FY26 (October-December 2025). The dramatic profit contraction came despite a modest 9.25% sequential revenue increase to ₹26.93 crores, as the company grappled with negative operating margins and heightened dependence on non-operating income. The stock has been under severe pressure, declining 44.60% over the past year and currently trading at ₹7.03, down 48.27% from its 52-week high of ₹13.59.

Read full news article

Vaishali Pharma Ltd is Rated Strong Sell

2026-05-24 10:10:15

Vaishali Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 Feb 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 24 May 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

View All News